Skip to content

Tackling HIV and hepatitis C in Europe: towards minimum standards

Dr Jerzy Jaroszewicz at the Standard of Care meeting. Photo by Valentin Boboc.

HIV infection an independent risk factor for poorer survival from liver cancer

Non-alcoholic fatty liver disease: a growing health problem in people with HIV

Barriers to HCV treatment access from the drug user's point of view: stigma, complex lives and damaged veins

Co-infection with HIV and HCV does not increase the risk of end-stage liver disease or liver cancer

Improved liver function, but progressive kidney damage, among children on antiretroviral therapy in Ethiopia

Australian experience shows high DAA uptake and rapid fall in rates of HCV viraemia among people who inject drugs

Hepatitis C is detectable in rectal and nasal fluid

Recent incarceration increases HIV and hepatitis C risk for people who inject drugs